Extension Approval End Date definition

Extension Approval End Date has the meaning specified in Section 9.02(c)(i).
Sample 1Sample 2
Extension Approval End Date. (clauses (A) and (B) together, the “Extension Proposals”). Buyer shall use best efforts to cause the Extension Proxy Statement to comply with all applicable Laws and to resolve any comments issued by the staff of the SEC with respect to the Extension Proxy Statement as promptly as practicable after such filing.
Sample 1Sample 2
Extension Approval End Date. Section 8.18(a) “Extension Expenses” Section 7.2(f)
Sample 1

Related to Extension Approval End Date

  • Non-Approval Event means, in respect of the Benchmark:

  • Term End Date means [Insert date];

  • MAA Approval means approval of an MAA by the applicable Regulatory Authority for marketing and sale of a Product in the Collaborator Territory, but excluding any Pricing and Reimbursement Approval.

  • HSR Approval means expiration of all applicable waiting periods under the HSR Act (including any voluntary agreed extensions) or earlier termination thereof.

  • Final Approval Date means the date on which the Court enters its Order and Judgment approving the Settlement.

  • Resolution Extension Period As defined in Section 2.03(b).

  • Approval Date means the date on which the Plan is approved by the Company’s stockholders.

  • Initial approval means authorization to admit students and enter into contractual agreements for clinical facilities. It is granted only after an application has been submitted, reviewed and a survey visit made by the Board. No students shall be admitted to the program until the institution has received written notification that initial approval has been granted. Failure to comply will delay initial approval.

  • CPUC Approval means a final and non-appealable order of the CPUC, without conditions or modifications unacceptable to the Parties, or either of them, which contains the following terms:

  • Extension Deadline means, with respect to a letter of credit, the Cutoff Time on the Business Day preceding the day on which the letter of credit expires.

  • Second Extension Period means a period of twelve (12) consecutive months following the First Extended Maturity Date.

  • NDA Approval means the Approval of an NDA by the FDA for a Product in the U.S.

  • Agreement End Date has the meaning specified in Section 10.1(e).

  • Initial Negotiation End Date has the meaning set forth in Section 12.2(a).

  • Required Effective Date means the relevant Initial Required Effective Date or Increased Required Effective Date (as those terms are defined below).

  • Increased Facility Closing Date any Business Day designated as such in an Increased Facility Activation Notice.

  • Preliminary Approval Date means the date on which the Court enters the Preliminary Approval Order.

  • Approval Notice means, with respect to any Eligible Loan Asset, the written notice, in substantially the form attached hereto as Exhibit A, evidencing the approval by the Administrative Agent, in its sole discretion, of the conveyance of such Eligible Loan Asset by the Transferor to the Borrower pursuant to the terms of the Purchase and Sale Agreement and the Loan Assignment by which the Transferor effects such conveyance.

  • Non-Extension Notice Date has the meaning specified in Section 2.03(b)(iii).

  • Extension Period has the meaning set forth in Section 2.11.

  • IRB approval means the determination of the IRB that the research has been reviewed and may be conducted at an institution within the constraints set forth by the IRB and by other institutional and federal requirements.

  • First Extension Period means a period of twelve (12) consecutive months following the Initial Maturity Date.

  • Additional Closing Date has the meaning set forth in Section 3.

  • Approval Letter means the letter from WRAS to the Applicant confirming the grant of WRAS Approval in respect of a Product;

  • Approval Application means a BLA, NDA or similar application or submission for a Product filed with a Regulatory Authority in a country or group of countries to obtain marketing approval for a biological or pharmaceutical product in that country or group of countries.